Hemophilus (e.g., Hemophilus influenzae, Hemophilus gallinarum, Hemophilus pleuropnemoniae, etc.)
Subclass of:
424 - Drug, bio-affecting and body treating compositions
424184100 - ANTIGEN, EPITOPE, OR OTHER IMMUNOSPECIFIC IMMUNOEFFECTOR (E.G., IMMUNOSPECIFIC VACCINE, IMMUNOSPECIFIC STIMULATOR OF CELL-MEDIATED IMMUNITY, IMMUNOSPECIFIC TOLEROGEN, IMMUNOSPECIFIC IMMUNOSUPPRESSOR, ETC.)
424234100 - Bacterium or component thereof or substance produced by said bacterium (e.g., Legionella, Borrelia, Anaplasma, Shigella, etc.)
Patent class list (only not empty are listed)
Deeper subclasses:
| Class / Patent application number | Description | Number of patent applications / Date published |
|---|---|---|
| 424256100 | Hemophilus (e.g., Hemophilus influenzae, Hemophilus gallinarum, Hemophilus pleuropnemoniae, etc.) | 11 |
| 20090017074 | CULTURE MEDIUM FOR HAEMOPHILUS INFLUENZAE TYPE B - The invention relates to a culture medium for | 01-15-2009 |
| 20090175912 | Haemophilus Influenza Outer Membrane Protein and Use Thereof in Vaccination - This invention relates to recombinant bacterial outer membrane proteins comprising one or more LB1(f) peptides from surface-exposed loop 3 of MOMP P5 of non-typeable | 07-09-2009 |
| 20100150967 | TREATMENT OR PROPHYLAXIS OF ASTHMA - There is provided a method for prophylaxis or treatment of asthma in an individual. The method comprises administering to the individual an effective amount of a Non-typable | 06-17-2010 |
| 20100255035 | Modified live (JMSO strain) Haemophilus parasuis vaccine - The present invention is a culture of cells of | 10-07-2010 |
| 20100285070 | POLYNUCLEOTIDES OF HAEMOPHILUS PARASUIS AND ITS USE - The present invention relates to | 11-11-2010 |
| 20110014237 | Vaccine for Protection Against Haemophilus Parasuis Serotype 4 in Piglets - The present invention pertains to the use of | 01-20-2011 |
| 20120093868 | HAEMOPHILUS INFLUENZAE TYPE B - Polypeptides comprising various amino acid sequences derived from | 04-19-2012 |
| 20120276145 | EXTRACELLULAR MATRIX PROTEINS FROM HAEMOPHILUS INFLUENZAE BIOFILMS: TARGETS FOR THERAPEUTIC OR DIAGNOSTIC USE - A method of identifying a biofilm that includes non-typeable | 11-01-2012 |
| 20140178435 | VACCINE COMPRISING INACTIVATED CELLS OF HAEMOPHILUS PARASUIS BACTERIA OF SEROTYPE 5 - The present invention pertains to the use of | 06-26-2014 |
| 20150098968 | HAEMOPHILUS PARASUIS VACCINE SEROVAR TYPE FOUR - The present invention is a | 04-09-2015 |
| 20150293092 | EXTRACELLULAR MATRIX PROTEINS FROM HAEMOPHILUS INFLUENZAE BIOFILMS: TARGETS FOR THERAPEUTIC OR DIAGNOSTIC USE - A method of identifying a biofilm that includes non-typeable | 10-15-2015 |